KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Active Biotech's Laquinimod Fails to Meet Primary Endpoint in Phase II Trial November 30, 2017 GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017 Bristol-Myers Squibb To Announce Results For First Quarter 2017 On April 27 March 9, 2017
GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017
